Evidence Explorer · MS-N228 · Supplements and cancer prevention · Appraised November 3, 2026
Vitamin D3, calcium, or both did not prevent recurrent conventional colorectal adenomas over three to five years. A later analysis found increased sessile serrated-polyp risk with calcium-containing assignments years after supplementation began.
Evidence at a glance
Benefit signal: No recurrent-adenoma prevention benefit
Certainty: High for no conventional-adenoma benefit at the studied doses; moderate for a delayed serrated-polyp safety signal
Risk context: Kidney stones, hypercalcemia, drug interactions and possible delayed serrated-polyp risk
What was studied
The randomized double-blind trial enrolled 2,259 adults after complete removal of adenomas. It tested vitamin D3 1,000 IU/day, calcium carbonate providing 1,200 mg elemental calcium/day, both, or neither for three to five years.
Recurrent adenoma risk ratios were 0.99 (95% CI 0.89–1.09) for vitamin D, 0.95 (0.85–1.06) for calcium and 0.93 (0.80–1.08) for both. In the later observational phase, sessile serrated-polyp risk was higher after calcium alone (adjusted RR 2.65, 95% CI 1.43–4.91) and calcium plus vitamin D (3.81, 1.25–11.64).
What this evidence cannot establish
The late serrated-polyp analysis was a secondary outcome after treatment ended and does not prove increased colorectal-cancer incidence.
These findings do not negate calcium or vitamin D for another established indication such as osteoporosis or deficiency; benefits and risks differ by person.
Practical safety context
Calcium and vitamin D can contribute to kidney stones or hypercalcemia and can interact with thyroid hormone, iron and some antibiotics. Total intake from diet and supplements matters.
People with kidney disease, sarcoidosis, hyperparathyroidism or prior stones need individualized advice.
Questions for the care team
- Is there a separate bone-health or deficiency indication for these supplements?
- What is my total calcium and vitamin D intake and kidney-stone risk?
- Does my colonoscopy history include serrated lesions, and what surveillance is recommended?
Sources
- Randomized calcium/vitamin D adenoma trial (PMID 26465985)
- Later serrated-polyp analysis (PMID 29496722)
Sources and publication status checked November 3, 2026. The delayed serrated-polyp result is preserved as a dated safety signal rather than silently folded into the null primary result.
For education, not personal medical advice. Nutrition and supplement decisions during cancer care should be individualized with the oncology and dietetics teams.
